heart iconheart icon
Skip to content

News Releases

 
News Releases
  Date Title and Summary View
Oct 17, 2017
NEW BRUNSWICK, N.J., Oct. 17, 2017 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced sales of $19.7 billion for the third quarter of 2017, an increase of 10.3% as compared to the third quarter of 2016. Operational sales results increased 9.5% and the positive impact of currency was 0.8%. Domestic sales increased 9.7%. International sale...
Oct 13, 2017
Oct 13, 2017
Oct 11, 2017
HORSHAM, Pa., Oct. 11, 2017 /PRNewswire/ -- Janssen Biotech, Inc. today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for apalutamide, an investigational, next generation oral androgen receptor (AR) inhibitor for men with non-metastatic castration-resistant prostate cancer (CRPC). Curren...
Oct 5, 2017
Oct 5, 2017
Oct 2, 2017
NEW BRUNSWICK, N.J., Oct. 2, 2017 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced the completion of the divestiture of its Codman Neurosurgery business to Integra LifeSciences Holding Corporation for an approximate value of $1.045 billion, subject to customary adjustments. The Codman Neurosurgery business offers a portfolio of ...
Oct 2, 2017
Sep 26, 2017
Sep 25, 2017
Page:
1
... NextLast
= add release to Briefcase